Targeted Non-Invasive PET Imaging of PD-L1-Expressing Colon Cancer Using a Zirconium-89 Radiolabeled Anti-PD-L1 Antibody

被引：0
|
作者：
Mulgaonkar, Aditi [2 ]
Hao, Guiyang [2 ]
Xiong, Yahong [2 ]
Tang, Haidong [1 ]
Nham, Kien [2 ]
Silvers, William [2 ]
Fu, Yang-Xin [1 ]
Sun, Xiankai [2 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Pathol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Radiol, Dallas, TX 75390 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
926
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immuno-PET using Zirconium-89 (89Zr) radiolabeled fully human anti-PD-L1 antibody successfully images PD-L1 positive tumors in preclinical mouse models
    Kelly, Marcus
    Giurleo, Jason
    Makonnen, Sosina
    Hickey, Carlos
    Arnold, T. Cody
    Ma, Dangshe
    Dai, Jie
    Pei, Jerry
    Tavare, Richard
    Kirshner, Jessica
    Olson, William
    Thurston, Gavin
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [2] Imaging of PD-L1 modulation by gemcitabine using 89Zr labeled anti-PD-L1 antibody PET.
    Jung, Kyung-Ho
    Park, Jin Won
    Lee, Jin Hee
    Cho, Young Seok
    Lee, Kyung-Han
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 90 - 91
  • [3] Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
    Heskamp, Sandra
    Hobo, Willemijn
    Molkenboer-Kuenen, Janneke D. M.
    Olive, Daniel
    Oyen, Wim J. G.
    Dolstra, Harry
    Boerman, Otto C.
    CANCER RESEARCH, 2015, 75 (14) : 2928 - 2936
  • [4] SPECT/CT imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies
    Heskamp, Sandra
    Hobo, Willemijn
    Molkenboer-Kuenen, Janneke
    Olive, Daniel
    Oyen, Wim
    Dolstra, Harry
    Boerman, Otto
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [5] Immuno-PET Imaging of 89Zr Labeled Anti-PD-L1 Domain Antibody
    Li, Dan
    Cheng, Siyuan
    Zou, Sijuan
    Zhu, Dongling
    Zhu, Tinghui
    Wang, Pilin
    Zhu, Xiaohua
    MOLECULAR PHARMACEUTICS, 2018, 15 (04) : 1674 - 1681
  • [6] PD-L1-expressing B cells promote murine breast cancer development and mediate response to anti-PD-L1 immune checkpoint inhibitor
    Cervantes, Christian
    Khan, Mustafa Tamim Alam
    Liu, Zexuan
    Viswanadhapalli, Suryavathi
    Gupta, Harshita
    Curiel, Tyler
    Yan, Hui
    Vadlamudi, Ratna
    Xu, Zhenming
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [7] DEVELOPMENT OF A NOVEL ZIRCONIUM-89 LABELLED ANTIBODY FOR IMAGING PD-L1 DYNAMICS IN MICE MESOTHELIOMA
    Mohamed, Shifaza
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 6 - 7
  • [8] Suppression of Endometriosis Using Anti-PD-L1 Antibody
    Mamillapalli, Ramanaiah
    Gawde, Nimisha
    Ucar, Abdullah
    Taylor, Hugh S.
    REPRODUCTIVE SCIENCES, 2023, 30 : 198A - 199A
  • [9] Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody
    Hasegawa, Hirotaka
    Sugiyama, Daisuke
    Kanda, Mitsuro
    Hayashi, Masamichi
    Tanaka, Chie
    Yamada, Suguru
    Nakayama, Goro
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    Nishikawa, Hiroyoshi
    CANCER SCIENCE, 2021, 112 : 741 - 741
  • [10] Pd-l1-expressing b-cells promote murine breast cancer development and mediate the response to anti-pd-l1 immune checkpoint inhibitor
    Khan, Mustafa Tamim Alam
    Cervantes, Christian
    Viswanadhapalli, Suryavathi
    Hui, Yan
    Vadlamudi, Ratna
    Xu, Zhenming
    CANCER RESEARCH, 2022, 82 (04)
12345